What is Xeljanz?

Xeljanz lawsuit attorneys Xeljanz law firm nj new jersey pa pennsylvaniaXeljanz is Pfizer's brand name for a drug referred to as tofacitinib citrate. Xeljanz was approved to take care of rheumatoid arthritis (“RA”) in 2012, psoriatric arthritis in 2017, and ulcerative colitis in 2018. Xeljanz is just a janus kinase 1 and 3 (“JAK”) inhibitor, which blocks enzymes that will cause inflammatory reactions. Because Xeljanz inhibits the immune system to be able to treat patients, it has a disclosed risk of serious conditions as a result of infections or related cancers. Based on safety concerns, Xeljanz hasn't been approved on the market in the European Union.

Unfortunately, the United States Federal Drug Administration (“FDA”) has found that: “[A]n increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR) was utilized in patients with rheumatoid arthritis (RA). FDA has not approved this 10 mg twice daily dose for RA; this dose is only approved in the dosing regimen for patients with ulcerative colitis.”

Do I Have a Claim? What're Xeljanz Side-Effects?

Xeljanz lawsuit law firms pic 3 nj nj pa pennsylvaniaIf you or a loved one have got 10 mg of Xeljanz twice each day to take care of rheumatoid arthritis (“RA”) and suffered the following serious injuries or side-effects:

Pulmonary embolism (“PE”)
Pulmonary thrombosis (“PT”)
Deep vein thrombosis (“DVT”)

You may have a possible claim for compensation against the makers of Xeljanz.

Our Xeljanz lawyers are experienced in MDL litigation cases and in negotiating with pharmaceutical settlement representatives. Contact us, free of charge, when you yourself have any questions.

Are You Impacted by the Potential Xeljanz Lawsuits ? You May Be Eligible for Compensation.

Whilst it continues to be very early and a significant amount of Xeljanz lawsuits have not even been filed, in the event that you or perhaps a loved one have got Xeljanz and suffered an injury, it is strongly recommended that you seek counsel with this Xeljanz attorneys, who're experienced in Xeljanz claims and injuries.

Earlier this season the FDA warned: “Patients should not stop or change your dose of tofacitinib without first conversing with your wellbeing care professional, as this may worsen your condition. Patients taking tofacitinib should seek medical attention immediately if you experience outward indications of a blood clot in your lungs and other unusual symptoms such as for instance:

Sudden shortness of breath or difficulty breathing
Chest pain or pain in your back
Coughing up blood
Excessive sweating
Clammy or bluish colored skin”

Stark & Stark Xeljanz attorneys are actively seeking Xeljanz settlements and filing Xeljanz lawsuits against drug makers on behalf of patients injured by these potentially defective drugs. If you think you took Xeljanz and suffered a blood clot injury, the Xeljanz attorneys at Stark & Stark can assist you to assess your potential claims.

For more details kindly visit xeljanz lawyer.